BlaidsX Micro vs Lexie B3

The BlaidsX Micro is a budget-priced OTC hearing aid that earned a B grade with a SoundScore of 3.0/5 in HearAdvisor's lab testing. At $499, it sits in the entry-level price tier but ranks #59 of 65 OTC hearing aids tested, placing it in the bottom portion of its category. In our testing, the BlaidsX Micro delivered mixed results across key performance areas. Its standout strength is excellent feedback handling, scoring a perfect 5.0/5 after tuning—0.46 points above the category average. This means users are unlikely to experience whistling or squealing during normal use. Speech in quiet environments scored 2.9/5, which is above the category average by 0.09 points, though this remains a mixed absolute score. The device shows notable weaknesses in several areas. Speech in noise performance is low at 1.0/5, falling 0.48 points below the OTC category average. Own-voice comfort also scored low at 1.0/5, sitting 1.51 points below average—users may notice their own voice sounds boomy or unnatural. Music streaming is not a viable use case with this device, scoring 0.0/5, which is 1.92 points below the category average. Budget-conscious shoppers should note that several competitors in the same price range offer significantly better overall performance, including the Elehear Beyond (4.34/5) and Apple AirPods Pro 2 (4.04/5). The BlaidsX Micro may suit buyers primarily concerned with feedback-free amplification in quiet settings, but those needing help in noisy environments or who want streaming capabilities should consider alternatives.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.